hs-CRP ELISA Kit (C-Reactive Protein)


Human hs-CRP ELISA kit is a method for analysing in vitro quantitative high sensitive concentrations c-reactive protein (hs-CRP) in human serum and plasma. This assay has a minimum detection limit of < 0.02 µg/ml.


C-reactive protein (CRP) has a total approx. molecular mass of 120.000 Daltons and is made up of a symmetrical pentamer structure. It is essentially a kind of non-immunoglobulin serum substance which is also a heat labile beta-globulin. The levels can increases dramatically after microbial infections and this property has been particularly helpful for the diagnosis and monitoring a large number of bacterial septicemia in neonates and in many other immune-compromised patients.

The concentrations of CRP begins to rise within 6 hours of an acute inflammatory challenge. Also, many injuries that are responsible for causing necrosis and tissue breakdown are also found to elevate serum levels, examples of these are observed in major surgery, myocardial infarction and thermal burns.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Coated Microtiterstrips: Coated with monoclonal antibodies to human CRP.
  • Standards (A-E): Concentrations 0, 0.4, 1, 5, 10 µg/ml.
  • Enzyme Conjugate.
  • Specimen Dilution Buffer (5x).
  • Washing Solution (20x).
  • TMB Chromogen Solution.
  • Stopping Solution.


The minimum detection sensitivity level of high sensitive c-reactive protein (CRP) using this hs-CRP ELISA kit was 0.02 µg/ml. The dynamic assay range for this kit is 0.4 – 10.0 µg /ml.


– Analytical Sensitivity: 0.02 µg/ml
– CRP values < 1.0 mg/L = Low risk for CVD.
-CRP values 1.0 – 2.9 mg/L = Intermediate risk for CVD
– CRP values > 3.0 mg/L = High risk for CVD
– Intra Assay Precision: 4.1 – 6.9%
– Inter Assay Precision: 5.8 – 6.3%
– Cross-Reactivity: Recognizes natural and recombinant human CRP.


  1. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently. Pacing Clin Electrophysiol. (2009) 32 (5): 648-52. Crandall M.A., et al.
  2. Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice. Am Heart Hosp J. (2004) 2 (4 Suppl 1): 4-9. Review. Ridker P.M.
  3. Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents. Clin Chem. (2009) 55 (2): 256-64. Review. Shen J. and Ordovas J.M.


  • Full Name: hs-CRP ELISA Kit (C-Reactive Protein)
  • Reactivity: Human
  • Sample Type: Plasma, Serum
  • Sensitivity: < 0.02 µg/ml


Online Enquiry Form

"*" indicates required fields

Please check mark information required:


Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford